Annals of Hepatology

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor


>Revistas >Annals of Hepatology >Año 2012, No. 3

Gutiérrez-Grobe Y, Chávez-Tapia N, Sánchez-Valle V, Gavilanes-Espinar JG, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N
High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity
Ann Hepatol 2012; 11 (3)

Idioma: Inglés
Referencias bibliográficas: 19
Paginas: 350-355
Archivo PDF: 82.80 Kb.

Texto completo


Sin resumen.

Palabras clave: Sin palabras Clave


  1. Sugiyama K, He P, Wada S, et al. Teas and other beverages suppress D-galactosamine-induced liver injury in rats. J Nutr 1999; 129: 1361-7.

  2. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992; 136: 1248-57.

  3. Johnson S, Koh WP, Wang R, et al. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 2011; 22: 503-10.

  4. Freedman ND, Curto TM, Lindsay KL, et al. Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology 2011; 140: 1961-9.

  5. Cherniack EP. Polyphenols: planting the seeds of treatment for the metabolic syndrome. Nutrition 2011; 27: 617-23.

  6. Mendez-Sanchez N, Chavez-Tapia NC, Zamora-Valdes D, et al. Hepatobiliary diseases and insulin resistance. Curr Med Chem 2007; 14: 1988-99.

  7. Mendez-Sanchez N, Arrese M, Zamora-Valdes D, et al. Treating nonalcoholic fatty liver disease. Liver Int 2007; 27: 1157-65.

  8. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5.

  9. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.

  10. Hernandez-Avila M, Romieu I, Parra S, et al. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Sal Pub Mex 1998; 40: 133-40.

  11. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.

  12. Kot M, Daniel WA. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat. Pharmacol Rep 2008; 60: 789-97.

  13. Yamauchi R, Kobayashi M, Matsuda Y, et al. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 2010; 58: 5597-603.

  14. Catalano D, Martines GF, Tonzuso A, et al. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 2010; 55: 3200-6.

  15. Delgado-Andrade C, Rufian-Henares JA, Morales FJ. Assessing the antioxidant activity of melanoidins from coffee brews by different antioxidant methods. J Agric Food Chem 2005; 53: 7832-6.

  16. Shin JW, Wang JH, Kang JK, et al. Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats. J Sci Food Agric 2010; 90: 450-5.

  17. Freedman ND, Everhart JE, Lindsay KL, et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009; 50: 1360-9.

  18. Klatsky AL, Morton C, Udaltsova N, et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006; 166: 1190-5.

  19. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007; 26: 1-8.

>Revistas >Annals of Hepatology >Año2012, No. 3

· Indice de Publicaciones 
· ligas de Interes 

Derechos Resevados 2019